Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma

Marin Kato, Hiroshi Nishihara, Hideyuki Hayashi, Taichi Kimura, Yusuke Ishida, Lei Wang, Masumi Tsuda, Mishie Ann Tanino, Shinya Tanaka

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Sox10, one of the transcription factors, regulates Wnt/β-catenin signaling in diverse developmental processes in normal tissues. Sox10 is also expressed in variable solid tumors such as breast cancer, salivary tumor, hepatocellular carcinoma, ovarian tumor, nasopharyngeal carcinoma, prostate cancer, and digestive cancer. The role of Sox10 during tumorigenesis is still controversial, especially in digestive cancers; thus, we performed clinicopathological evaluation of Sox10 expression in 41 cases of diffuse-type gastric adenocarcinoma (DGA). We examined the expression of Sox10 by immunohistochemical staining and real-time quantitative reverse transcriptase PCR and evaluated the correlation between Sox10 expression and clinicopathological factors. A low-level expression of Sox10 was significantly associated with high-level venous invasion by immunohistochemical evaluation, while it was significantly associated with high-level lymphatic permeation when analyzed by real-time PCR assay. Survival analysis of 41 cases indicated that high level of vascular permeation was a statistically poor prognostic factor, suggesting that derogation of Sox10 would lead to unfavorable patients’ outcome through the acceleration of vascular invasion. In this study, we revealed the clinical benefit of evaluation of Sox10 expression to predict the risk of vascular permeation which yields patients’ poor prognosis in DGA.

Original languageEnglish
Article number8
JournalMedical Oncology
Volume34
Issue number1
DOIs
Publication statusPublished - 2017 Jan 1
Externally publishedYes

Fingerprint

Stomach
Adenocarcinoma
Blood Vessels
Neoplasms
Catenins
Survival Analysis
Reverse Transcriptase Polymerase Chain Reaction
Real-Time Polymerase Chain Reaction
Hepatocellular Carcinoma
Prostatic Neoplasms
Carcinogenesis
Transcription Factors
Staining and Labeling
Breast Neoplasms

Keywords

  • Diffuse-type gastric cancer
  • Immunohistochemistry
  • Lymphatic invasion
  • Prognostic factor
  • Real-time PCR
  • Venous invasion

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma. / Kato, Marin; Nishihara, Hiroshi; Hayashi, Hideyuki; Kimura, Taichi; Ishida, Yusuke; Wang, Lei; Tsuda, Masumi; Tanino, Mishie Ann; Tanaka, Shinya.

In: Medical Oncology, Vol. 34, No. 1, 8, 01.01.2017.

Research output: Contribution to journalArticle

Kato, Marin ; Nishihara, Hiroshi ; Hayashi, Hideyuki ; Kimura, Taichi ; Ishida, Yusuke ; Wang, Lei ; Tsuda, Masumi ; Tanino, Mishie Ann ; Tanaka, Shinya. / Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma. In: Medical Oncology. 2017 ; Vol. 34, No. 1.
@article{4a273e0debc24d4087b116497bba7224,
title = "Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma",
abstract = "Sox10, one of the transcription factors, regulates Wnt/β-catenin signaling in diverse developmental processes in normal tissues. Sox10 is also expressed in variable solid tumors such as breast cancer, salivary tumor, hepatocellular carcinoma, ovarian tumor, nasopharyngeal carcinoma, prostate cancer, and digestive cancer. The role of Sox10 during tumorigenesis is still controversial, especially in digestive cancers; thus, we performed clinicopathological evaluation of Sox10 expression in 41 cases of diffuse-type gastric adenocarcinoma (DGA). We examined the expression of Sox10 by immunohistochemical staining and real-time quantitative reverse transcriptase PCR and evaluated the correlation between Sox10 expression and clinicopathological factors. A low-level expression of Sox10 was significantly associated with high-level venous invasion by immunohistochemical evaluation, while it was significantly associated with high-level lymphatic permeation when analyzed by real-time PCR assay. Survival analysis of 41 cases indicated that high level of vascular permeation was a statistically poor prognostic factor, suggesting that derogation of Sox10 would lead to unfavorable patients’ outcome through the acceleration of vascular invasion. In this study, we revealed the clinical benefit of evaluation of Sox10 expression to predict the risk of vascular permeation which yields patients’ poor prognosis in DGA.",
keywords = "Diffuse-type gastric cancer, Immunohistochemistry, Lymphatic invasion, Prognostic factor, Real-time PCR, Venous invasion",
author = "Marin Kato and Hiroshi Nishihara and Hideyuki Hayashi and Taichi Kimura and Yusuke Ishida and Lei Wang and Masumi Tsuda and Tanino, {Mishie Ann} and Shinya Tanaka",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/s12032-016-0865-2",
language = "English",
volume = "34",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma

AU - Kato, Marin

AU - Nishihara, Hiroshi

AU - Hayashi, Hideyuki

AU - Kimura, Taichi

AU - Ishida, Yusuke

AU - Wang, Lei

AU - Tsuda, Masumi

AU - Tanino, Mishie Ann

AU - Tanaka, Shinya

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Sox10, one of the transcription factors, regulates Wnt/β-catenin signaling in diverse developmental processes in normal tissues. Sox10 is also expressed in variable solid tumors such as breast cancer, salivary tumor, hepatocellular carcinoma, ovarian tumor, nasopharyngeal carcinoma, prostate cancer, and digestive cancer. The role of Sox10 during tumorigenesis is still controversial, especially in digestive cancers; thus, we performed clinicopathological evaluation of Sox10 expression in 41 cases of diffuse-type gastric adenocarcinoma (DGA). We examined the expression of Sox10 by immunohistochemical staining and real-time quantitative reverse transcriptase PCR and evaluated the correlation between Sox10 expression and clinicopathological factors. A low-level expression of Sox10 was significantly associated with high-level venous invasion by immunohistochemical evaluation, while it was significantly associated with high-level lymphatic permeation when analyzed by real-time PCR assay. Survival analysis of 41 cases indicated that high level of vascular permeation was a statistically poor prognostic factor, suggesting that derogation of Sox10 would lead to unfavorable patients’ outcome through the acceleration of vascular invasion. In this study, we revealed the clinical benefit of evaluation of Sox10 expression to predict the risk of vascular permeation which yields patients’ poor prognosis in DGA.

AB - Sox10, one of the transcription factors, regulates Wnt/β-catenin signaling in diverse developmental processes in normal tissues. Sox10 is also expressed in variable solid tumors such as breast cancer, salivary tumor, hepatocellular carcinoma, ovarian tumor, nasopharyngeal carcinoma, prostate cancer, and digestive cancer. The role of Sox10 during tumorigenesis is still controversial, especially in digestive cancers; thus, we performed clinicopathological evaluation of Sox10 expression in 41 cases of diffuse-type gastric adenocarcinoma (DGA). We examined the expression of Sox10 by immunohistochemical staining and real-time quantitative reverse transcriptase PCR and evaluated the correlation between Sox10 expression and clinicopathological factors. A low-level expression of Sox10 was significantly associated with high-level venous invasion by immunohistochemical evaluation, while it was significantly associated with high-level lymphatic permeation when analyzed by real-time PCR assay. Survival analysis of 41 cases indicated that high level of vascular permeation was a statistically poor prognostic factor, suggesting that derogation of Sox10 would lead to unfavorable patients’ outcome through the acceleration of vascular invasion. In this study, we revealed the clinical benefit of evaluation of Sox10 expression to predict the risk of vascular permeation which yields patients’ poor prognosis in DGA.

KW - Diffuse-type gastric cancer

KW - Immunohistochemistry

KW - Lymphatic invasion

KW - Prognostic factor

KW - Real-time PCR

KW - Venous invasion

UR - http://www.scopus.com/inward/record.url?scp=85003875985&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85003875985&partnerID=8YFLogxK

U2 - 10.1007/s12032-016-0865-2

DO - 10.1007/s12032-016-0865-2

M3 - Article

C2 - 27943102

AN - SCOPUS:85003875985

VL - 34

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 1

M1 - 8

ER -